直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Performing a Claimed Method for Compensation Triggers the On-sale Bar, Even Where No Product is Sold

June 6, 2019

Authored and Edited by Bonnie Fletcher Price, Ph.D.; Kevin D. Rodkey; Elizabeth D. Ferrill

In Quest Integrity USA, LLC v. Cokebusters USA Inc., No. 2017-2423 (Fed. Cir. May 21, 2019), the Federal Circuit affirmed the district court’s grant of summary judgement invalidating three claims of U.S. Patent No. 75,542,874 under the on-sale bar of 35 U.S.C. § 102(b) and reversed and remanded to the district court to determine the validity of two remaining claims.

Quest asserted five claims of the ’784 patent, which relates to displaying inspection data collected from commercial furnace tubes, against Cokebusters. Cokebusters asserted that the claims were invalid under the § 102(b) on-sale bar because Quest inspected a client’s furnace tubes and created a set of reports for that client using the claimed method and systems more than one year prior to filing the patent. The district court found all asserted claims invalid on summary judgment. Quest appealed.

On appeal, the Federal Circuit reiterated that “[p]erformance of a claimed method for compensation, or a commercial offer to perform the method, can also trigger the on-sale bar, even where no product is sold or offered for sale.” Because the prior method used by Quest embodied three of the claims, the court affirmed the invalidity of those claims. Regarding the remaining two claims, the court found that the Quest’s affidavit created a genuine issue of material fact whether Quest’s pre-patent method embodied one of the claim elements. The court rejected the district court’s reasoning that Quest’s affidavit opposing summary judgment was a “sham affidavit,” explaining that evidence of record reasonably explained and corroborated the affidavit. The court thus reversed the invalidity finding of the two remaining claims and remanded for further proceedings.

Tags

prior use (35 USC § 102), prior sale, summary judgment

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Contacts

Kevin D. Rodkey
Partner
Atlanta, GA
+1 404 653 6484
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2019 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information. 

Related Insights

Conference

2027 ABA-IPL Section Annual Meeting – IPLSPRING

April 14-15, 2027

Arlington

Reception

2026 IPO Education Foundation Awards Dinner

December 15, 2026

Washington, DC

Conference

IP Life Sciences Forum 2026

December 13-15, 2026

Coral Gables

Conference

Atlantic Basin Conference on Chemistry 2026

December 6-9, 2026

Rio de Janeiro

Panel Discussion

2026 Advanced Patent Law Institute

December 3-4, 2026

Stanford

Webinar

Data and Market Exclusivity: An Update on China’s New Law and Comparisons to the US and Europe

November 19, 2026

Webinar

Conference

IPBC Asia 2026

November 17-19, 2026

Tokyo

Conference

NAPABA Convention 2026

November 12-14, 2026

Los Angeles

Conference

Broad's 3rd Annual Biotech IP Summit

November 10, 2026

Cambridge

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP